Acelrx Pharmaceuticals Inc

NASDAQ:ACRX  
1.14
+0.01 (+0.88%)
Earnings Announcements

Acelrx Pharmaceuticals Posts Q4 Loss Per Share Of $0.10

Published: 03/15/2021 20:24 GMT
Acelrx Pharmaceuticals Inc (ACRX) - Acelrx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results.
Q4 Loss per Share $0.10.
Q4 Earnings per Share Estimate $-0.10 -- Refinitiv Ibes Data (analyst estimates).
Q4 Revenue $700,000.
Q4 Revenue Estimate $2.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.06 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $1.81 Million
Next Quarter EPS Guidance is expected to be -$0.08

More details on our Analysts Page.